Related references
Note: Only part of the references are listed.Platelet-derived growth factor-BB accelerates prostate cancer growth by promoting the proliferation of mesenchymal stem cells
Jiwen Cheng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk
Karl Staser et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice
Tiffany Chang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
Walter J. Jessen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate
A. Schindeler et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2011)
The Haploinsufficient Hematopoietic Microenvironment Is Critical to the Pathological Fracture Repair in Murine Models of Neurofibromatosis Type 1
Xiaohua Wu et al.
PLOS ONE (2011)
Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive Activity
Yongzheng He et al.
PLOS ONE (2011)
Bone marrow-derived mesenchymal stem cells and the tumor microenvironment
Scott A. Bergfeld et al.
CANCER AND METASTASIS REVIEWS (2010)
Local Low-Dose Lovastatin Delivery Improves the Bone-Healing Defect Caused by Loss of Function in Osteoblasts
Weixi Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin
Mateusz Kolanczyk et al.
BMC MEDICINE (2008)
Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice
Aaron Schindeler et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2008)
Models of tibial fracture healing in normal and Nf1-deficient mice
Aaron Schindeler et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2008)
Tumor microenvironment and neurofibromatosis type I: connecting the GAPs
L. Q. Le et al.
ONCOGENE (2007)
Extracellular signal-regulated kinase 1/2 is involved in ascorbic acid-induced osteoblastic differentiation in periodontal ligament cells
Kaori Mimori et al.
JOURNAL OF PERIODONTOLOGY (2007)
Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development
Chunxi Ge et al.
JOURNAL OF CELL BIOLOGY (2007)
Bone mineral density in children and adolescents with neurofibromatosis type 1
David A. Stevenson et al.
JOURNAL OF PEDIATRICS (2007)
Erk pathways negatively regulate matrix mineralization
Shin-jiro Kono et al.
BONE (2007)
ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae
Florent Elefteriou et al.
CELL METABOLISM (2006)
Hyperactivation of p21ras and PI3K cooperate to after murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions
Feng-Chun Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells
Xiaohua Wu et al.
HUMAN MOLECULAR GENETICS (2006)
Double inactivation of NF1 in tibial pseudarthrosis
DA Stevenson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Pathophysiology of neurofibromatosis type 1
Amy Theos et al.
ANNALS OF INTERNAL MEDICINE (2006)
Vasculopathy in two cases of NFI-related congenital pseudarthrosis
Tommi Kuorilehto et al.
PATHOLOGY RESEARCH AND PRACTICE (2006)
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
LG Raisz
JOURNAL OF CLINICAL INVESTIGATION (2005)
Decreased bone mineral density in patients with neurofibromatosis 1
M Lammert et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Decreased bone mineral density and content in neurofibromatosis type 1:: Lowest local values are located in the load-carrying parts of the body
T Kuorilehto et al.
OSTEOPOROSIS INTERNATIONAL (2005)
The NF1 tumor suppressor critically regulates TSC2 and mTOR
CM Johannessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Imaging features of neurofibromatosis type 1
C Jacques et al.
JOURNAL OF NEURORADIOLOGY (2005)
Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning
X Yu et al.
BONE (2005)
Macrophage inflammatory protein 2 inhibits β-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways
K Watson et al.
MOLECULAR PHARMACOLOGY (2005)
Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues
F Liu et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2004)
NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos
T Kuorilehto et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
The same cellular signaling pathways mediate survival in sensory neurons that switch their trophic requirements during development
SB Salvarezza et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization
LD Meirelles et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix
C Higuchi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Mouse α1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast
R Dacquin et al.
DEVELOPMENTAL DYNAMICS (2002)
Neurofibromas in NF1: Schwann cell origin and role of tumor environment
Y Zhu et al.
SCIENCE (2002)
Hyperactivation of p21ras and the hematopoietic-specific Rho GTPase Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro
DA Ingram et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The neurofibromatoses: when less is more
DH Gutmann
HUMAN MOLECULAR GENETICS (2001)
Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells
KK Hiatt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
NF1 tumor suppressor gene function: Narrowing the GAP
K Cichowski et al.
CELL (2001)
Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities
T Illes et al.
OSTEOPOROSIS INTERNATIONAL (2001)
The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat
MN Ajuebor et al.
JOURNAL OF IMMUNOLOGY (2001)
Inactivation of Ca2+ action potential channels by the MEK inhibitor PD98059
MC Gould et al.
EXPERIMENTAL CELL RESEARCH (2000)
The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice
RP Atit et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1
JL Rutkowski et al.
HUMAN MOLECULAR GENETICS (2000)
Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo
DA Ingram et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Pathology of bone lesions associated with congenital pseudarthrosis of the leg
E Ippolito et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B (2000)
Mitogen activated protein kinase inhibition by PD98059 blocks nerve growth factor stimulated axonal outgrowth from adult mouse dorsal root ganglia in vitro
B Sjogreen et al.
NEUROSCIENCE (2000)
Share Paper
